Starting from 31 July, a new vaccination programme for Meningitis B will be rolled out in Northern Ireland, targeting Year 14 pupils and under-25s entering university. This initiative comes in response to a recent outbreak that resulted in fatalities among young individuals, highlighting the vulnerability of this age group to the disease.
The two-dose vaccine aims to protect those most at risk, particularly as students often live in close quarters, increasing the likelihood of transmission. The rollout will also include a mixed delivery model, utilizing GPs, community pharmacies, and vaccination clinics on university campuses to ensure accessibility.
Health experts are advocating for a broader vaccination campaign, suggesting that all teenagers aged 15 and above should receive the MenB vaccine. This shift in recommendation reflects a growing recognition of the risks associated with meningitis in young populations, especially as they transition to university life.
The first doses will be available until the end of December 2026, with second doses offered until March 2027, allowing ample time for students, including late arrivals and international students, to complete their vaccinations before starting their studies.
Source: BBC News
